Arcutis Biotherapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Arcutis Biotherapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2018 to 2023.
  • Arcutis Biotherapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $10.2M, a 2.42% increase year-over-year.
  • Arcutis Biotherapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $41.6M, a 5.67% increase year-over-year.
  • Arcutis Biotherapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $38.8M, a 18.8% increase from 2022.
  • Arcutis Biotherapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $32.7M, a 36.8% increase from 2021.
  • Arcutis Biotherapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $23.9M, a 201% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $38.8M +$6.13M +18.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 $32.7M +$8.79M +36.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 $23.9M +$15.9M +201% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 $7.94M +$7.12M +864% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $824K +$673K +446% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-22
2018 $151K Jan 1, 2018 Dec 31, 2018 10-K 2021-02-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.